Prévalence et description du traitement par hypotonisants pour glaucome et hypertonie oculaire en France

On the basis of this first nationwide study, it can be estimated that the prevalence of subjects treated with IOP-lowering topical medications is about 1.2 million in France. The number of daily doses appears to influence compliance.